Home › Funds › ADAR1 Capital Management, LLC › NRIX

ADAR1 Capital Management, LLC position in NRIX

NURIX THERAPEUTICS INC · Health Care

ADAR1 Capital Management, LLC reported holding 813,236 shares of NRIX (NURIX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$19.3M, representing 1.06% of its reported portfolio and ranking #20 among its reported holdings. ADAR1 Capital Management, LLC has disclosed NRIX holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)813.24K sh
Reported value held$19.28M
Portfolio Weight1.06%
First reportedQ1 2024
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's NRIX position evolved

ADAR1 Capital Management, LLC first disclosed a stake in NRIX in Q1 2024 at 35,608 shares (US$523K). The position peaked in Q3 2026 at 813,236 shares, worth US$19.3M. Across 10 filings, ADAR1 Capital Management, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 813,236 shares valued at US$19.3M — an increase of 500,000 shares quarter over quarter.. Notable position changes include a 131% increase in Q4 2025 (shares fell 18% over the following quarter), a 459% increase in Q2 2026 (shares fell 2% over the following quarter), a 160% increase in Q3 2026 (shares fell 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 35.61K $523.44K New
Q2 2024 3.50K $73.05K Reduce
Q4 2024 11.00K $207.24K New
Q1 2025 21.20K $251.86K Add
Q2 2025 31.20K $355.37K Add
Q3 2025 31.20K $288.29K Hold
Q4 2025 72.07K $1.37M Add
Q1 2026 56.07K $869.09K Reduce
Q2 2026 313.24K $7.60M Add
Q3 2026 813.24K $19.28M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRIX and 13F data

NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 47 other funds we track also report a position in NRIX — the largest reported positions include Vestal Point Capital, LP (US$195.3M), Rubric Capital Management LP (US$175.3M), Deep Track Capital, LP (US$142.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRIX

All NRIX fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held NRIX?

ADAR1 Capital Management, LLC has disclosed NRIX holdings in 10 of the last 11 reported quarters, going back to Q1 2024.

What is ADAR1 Capital Management, LLC's current position in NRIX?

As of Q3 2026, ADAR1 Capital Management, LLC holds 813.24K shares of NRIX (NURIX THERAPEUTICS INC), valued at $19.28M, representing 1.06% of its reported portfolio and ranking #20.

Has ADAR1 Capital Management, LLC been buying or selling NRIX?

In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC increased its position in NRIX. The position peaked in Q3 2026 at 813.24K shares.

Which other funds hold NRIX?

Other major institutional holders of NRIX include Vestal Point Capital, LP, Rubric Capital Management LP, Deep Track Capital, LP, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.